High co-payment costs prompt between 6% and 25% of oncology patients to walk away from the pharmacy counter without filling their prescriptions for eight oral cancer drugs, according to a report funded by five large pharmacy manufacturers.
According to the report, 6% of oncology patients whose prescription co-payment was $100 or less decided to void the purchase after learning the cost. About 25% didn't purchase the prescription medication when they learned co-payments or cost-sharing would require them to pay more than $500.
Friday, May 20, 2011
Up to 1 in 4 Patients Skip Oral Cancer Drugs on Costs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment